These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin. Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546 [TBL] [Abstract][Full Text] [Related]
8. Total synthesis of (-)-virginiamycin M2. Wu J; Panek JS Angew Chem Int Ed Engl; 2010 Aug; 49(35):6165-8. PubMed ID: 20648503 [No Abstract] [Full Text] [Related]
9. CCK-8-related C-terminal tetrapeptides: affinities for central CCKB and peripheral CCKA receptors. Harhammer R; Schäfer U; Henklein P; Ott T; Repke H Eur J Pharmacol; 1991 Dec; 209(3):263-6. PubMed ID: 1797567 [TBL] [Abstract][Full Text] [Related]
10. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists. Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123 [No Abstract] [Full Text] [Related]
11. Combined dose-ratio analysis for the CCK-B antagonist virginiamycin in guinea pig ileum. Corsi M; Dal Forno G; Oliosi B; Pietra C; van Amsterdam FT; Trist DG Ann N Y Acad Sci; 1994 Mar; 713():353-4. PubMed ID: 8185185 [No Abstract] [Full Text] [Related]
12. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand. Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696 [TBL] [Abstract][Full Text] [Related]
13. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists. Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834 [TBL] [Abstract][Full Text] [Related]
14. Evidence for two cholecystokinin receptors mediating the contraction of the guinea pig isolated ileum longitudinal muscle myenteric plexus. Dal Forno G; Pietra C; Urciuoli M; van Amsterdam FT; Toson G; Gaviraghi G; Trist D J Pharmacol Exp Ther; 1992 Jun; 261(3):1056-63. PubMed ID: 1602372 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists. Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds. Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054 [TBL] [Abstract][Full Text] [Related]
17. Structural features of various proglumide-related cholecystokinin receptor antagonists. Jensen RT; Zhou ZC; Murphy RB; Jones SW; Setnikar I; Rovati LA; Gardner JD Am J Physiol; 1986 Dec; 251(6 Pt 1):G839-46. PubMed ID: 2431626 [TBL] [Abstract][Full Text] [Related]
18. Distinct cholecystokinin receptors in brain and pancreas. Innis RB; Snyder SH Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6917-21. PubMed ID: 6256771 [TBL] [Abstract][Full Text] [Related]
19. Quinolone derivatives: synthesis and binding evaluation on cholecystokinin receptors. Varnavas A; Lassiani L; Luxich E; Zacchigna M; Boccù E; Pichierri F Farmaco; 1996 May; 51(5):341-50. PubMed ID: 8767844 [TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility. Bock MG; DiPardo RM; Rittle KE; Evans BE; Freidinger RM; Veber DF; Chang RS; Chen TB; Keegan ME; Lotti VJ J Med Chem; 1986 Oct; 29(10):1941-5. PubMed ID: 3761313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]